Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer

doi:10.3877/cma.j.issn.2095-3224.2018.05.006

Abstract

Abstract:

Objective

To study the role of long non-coding RNA H19 in the chemosensitivity of colorectal cancer.

Methods

The colon cancer cell lines stably overexpressed and silenced with lncRNA H19 were constructed and cultured in 5-FU. The expression of H19 was detected by RT-qPCR. The cell proliferation rate was measured by MTT assay. The migration ability of each group was evaluated by scratch test. The protein expressions of MDR1, MRP1 and BCRP were detected by Western blot.

Results

Compared with normal cells, the expression of lncRNA H19 increased, and the proliferation rate of lncRNA H19 stable overexpression group was significantly higher than that of H19 silencing group. The migration distance in lncRNA H19 stable overexpression group was significantly longer than that in H19 silencing group and the overexpression of bcl-2 protein was down-regulated and bax、MDR1、MRP1 and BCRP was up-regulated in lncRNA H19 stable overexpression group. The expression of bcl-2 protein was up-regulated and the expression of bax、MDR1、MRP1 and BCRP was down-regulated in H19 silencing group.

Conclusion

Colorectal cancer with high expression of lncRNA H19 reduces the sensitivity of colorectal cancer to chemotherapeutic drugs, and down-regulation of lncRNA H19 expression can improve the curative effect of chemotherapy drugs.

Key words: Colorectal neoplasms, lncRNA H19, Chemosensitivity, Long Noncoding RNA, Apoptosis

Xiumei Wang, Haiping Zhao, Qiong Qin, Yongqiang Liu, Bing Zhang, Yongsheng Wu. Role of long noncoding RNA H19 in chemosensitivity of colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(05): 437-441.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2018.05.006

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2018/V07/I05/437

Figures/Tables 5

References 18

[1]	Siegel RL, Miller KD, Jemal A.Cancer statistics, 2015 [J]. CA Cancer J Clin，2016, 66(1):7-30
[2]	Song M, Garrett WS, Chan A. Nutrients, foods, and colorectal cancer prevention [J]. Gastroenterology, 2015, 148(6):1244-1260.
[3]	Boeckx N, Janssens K, Van Camp G, et al. The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review [J]. Crit Rev Oncol Hematol, 2018, 121:1-10.
[4]	Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[5]	Kunej T, Obsteter J, Pogacar Z, et al. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring [J]. Crit Rev Clin Lab Sci, 2014, 51(6):344-357.
[6]	Luo J, Qu J, Wu DK, et al. Long non-coding RNAs: a rising biotarget in colorectal cancer [J]. Oncotarget, 2017, 8(13):22187-22202.
[7]	Fanale D, Castiglia M1, Bazan V, et al. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer [J]. Adv Exp Med Biol, 2016, 937:207-228.
[8]	Collette J, Le Bourhis X, Adriaenssens E. Regulation of Human Breast Cancer by the Long Non-Coding RNA H19 [J]. Int J Mol Sci, 2017, 18(11). pii:E2319.
[9]	王胜杰，翟从劼，姜霞, 等. 结直肠癌相关长链非编码RNA的研究进展 [J]. 山东医药, 2017, 57(24):97-99.
[10]	黄东宁，梁小娜.长链非编码RNA在结直肠癌中的研究进展 [J]. 实用肿瘤学杂志, 2015, 29(3):263-266.
[11]	Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development [J]. DNA Repair (Amst), 2016, 45:25-33.
[12]	Cai X, Cullen BR.The imprinted H19 noncoding RNA is a primary microRNA precursor [J]. RNA.2007, 13(3):313-316.
[13]	Li H, Li J, Jia S, et al. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer [J]. Oncotarget, 2015, 6(31):31958-31984.
[14]	Tong M, Zheng W, Li H, et al. Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy [J]. Oncogenesis, 2016, 5(7):e242.
[15]	Li X, Cai H, Zheng W, et al. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups [J]. Oncotarget, 2016, 7(8):8743-8755.
[16]	Jo YK, Park NY, Shin JH, et al. Up-regulation of UVRAG by HDAC1 inhibition attenuates 5FU-induced cell death in HCT116 colorectal cancer cells [J]. Anticancer Res, 2018, 38(1):271-277.
[17]	Zhang X, Chen Y, Hao L, et al. Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine [J]. Cancer Lett, 2016, 381(2):305-313.
[18]	Han D, Gao X, Wang M, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 [J]. Oncotarget, 2016, 7(16):22159-22173.

Please choose a citation manager

Content to export